Last updated: September 30, 2022
Sponsor: Ospedale Regionale di Lugano
Overall Status: Active - Recruiting
Phase
N/A
Condition
Chronic Pain
Treatment
N/AClinical Study ID
NCT05402631
The EXPECT study
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria
Subjects fulfilling all of the following inclusion criteria are eligible for the investigation:
Age > 18 years old.
Patients treated with a fluoroscopic guided lumbar epidural injection (transforaminal/translaminar/caudal) for back and/or leg pain
Exclusion criteria The presence of any one of the following exclusion criteria will lead to the exclusion of the subject
patients who did not complete the questionnaires
patient did not sign the general consent form (EOC_M-AFRI-001/A)
Study Design
Total Participants: 80
Study Start date:
April 20, 2022
Estimated Completion Date:
September 30, 2022
Study Description
Connect with a study center
Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland
Lugano, 6900
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.